These findings highlight the tumor‐promoting effects of downregulated expression of miR‐326 and ARRB1 in MB cells, whose biological convergence includes impairment of apoptosis and differentiation, along with enhancement of the CSC component's pluripotency and clonogenicity. Here, ARRB1 is linked to neoplasm.